Therapeutic HBV Vaccine to Target Internal Viral Proteins: Clinical Development

Time: 5:45 pm
day: Day One Morning


  • Methods Vaccines are delivered by chimpanzee adenovirus vectors (AdC) of serotype 6 (AdC6) and 7 (AdC7) used in prime only or prime-boost regimens
  • Results show that the vaccines are immunogenic in mice and induce potent CD8⁺ T cell responses that recognize multiple epitopes